[Health care access of Sub-Saharan African migrants living with chronic hepatitis B]

Sante Publique. 2017 Jul 10;29(3):361-370.
[Article in French]

Abstract

Objective: The objective of this study was to analyse health care access of Sub-Saharan African migrants living with chronic hepatitis B (CHB) in France. Methods: The ANRS-Parcours survey was a life-event survey conducted in 2012-2013 among Sub-Saharan African migrants recruited by health care facilities managing CHB in the Paris region. Data were collected by face-to-face interview using a biographical grid and a standardized questionnaire. Results: 96.4% of the 619 participants basic health insurance coverage with CMU universal health insurance coverage in 18.6% of cases and AME state medical assistance in 23.4% of cases. One-third of basic health insurance beneficiaries did not have any complementary health insurance and 75.7% had long-term disease status. The median time to acquisition of health insurance cover after arrival in France was one year. 22.0% of participants reported delaying health care for financial reasons since their arrival in France and 9.7% reported being refused health care usually due to refusal of CMU or AME. Health care access was effective within one year of the diagnosis. Delayed health care access was more common among people without health insurance coverage in the year of diagnosis. Patients lost to follow-up for more than 12 months were rare. Conclusion: Sub-Saharan African migrants living with chronic hepatitis B rapidly access health insurance coverage and health care. However, barriers to health care access persist for some people, essentially due to absent or incomplete health insurance cover and refusal of care for AME or CMU beneficiaries.

Keywords: Health Care Quality; access; evaluation; health insurance coverage; migrants; Sub-saharan Africa; France; hepatitis B.

MeSH terms

  • Adolescent
  • Adult
  • Africa South of the Sahara / ethnology
  • Female
  • France
  • Health Services Accessibility / statistics & numerical data*
  • Hepatitis B, Chronic* / therapy
  • Humans
  • Male
  • Middle Aged
  • Transients and Migrants*
  • Young Adult